SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-24-045207
Filing Date
2024-04-09
Accepted
2024-04-09 16:01:57
Documents
4
Period of Report
2024-05-13

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm249597-2_def14a.htm DEF 14A 422841
2 GRAPHIC lg_neubase-bw.jpg GRAPHIC 10505
3 GRAPHIC px_nsbeproxy1pg01-4c.jpg GRAPHIC 353821
4 GRAPHIC px_nsbeproxy1pg02-bw.jpg GRAPHIC 167609
  Complete submission text file 0001104659-24-045207.txt   1101096
Mailing Address 350 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 350 TECHNOLOGY DRIVE PITTSBURGH PA 15219 412-763-3350
NeuBase Therapeutics, Inc. (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35963 | Film No.: 24832678
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)